Fazirsiran reduces liver Z-alpha-1 antitrypsin synthesis, decreases globule burden and improves histological measures of liver disease in adults with alpha-1 antitrypsin deficiency: a randomized placebo-controlled phase 2 study Clark, V., Strange, C., Strnad, P., Sanchez, A., Kwo, P., Pereira, V., Van Hoek, B., Barjaktarevic, I., Corsico, A., Pons, M., Goldklang, M., Gray, M., Kuhn, B., Vargas, H., Vierling, J. M., Vuppalanchi, R., Brantly, M., Kappe, N., Chang, T., Schluep, T., Yi, M., Hamilton, J., San Martin, J., Loomba, R. ELSEVIER. 2023: S90-S91

View details for Web of Science ID 001037135100135